These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 36651019

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A, Parladori R, Mori F, Liccioli G, Bassi A, Lanari M, Patrizi A, Neri I.
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [Abstract] [Full Text] [Related]

  • 5. Comparison of cyclosporine and systemic corticosteroid for treating drug reaction with eosinophilia and systemic symptoms syndrome: A retrospective 20-year single-centre study in South Korea.
    Kwon HJ, Yoon JH.
    Australas J Dermatol; 2023 Feb; 64(1):50-57. PubMed ID: 36695042
    [Abstract] [Full Text] [Related]

  • 6. Corticosteroid-induced drug reaction with eosinophilia and systematic symptoms successfully treated with a tumor necrosis factor alpha inhibitor.
    Kim S, Joo EJ, Kim UJ, Kim JH, Kim B, Lee HJ, Chae SW, Kim HN, Cheong HS.
    Asian Pac J Allergy Immunol; 2022 Dec; 40(4):418-421. PubMed ID: 32170921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
    Hon KL, Luk DCK, Leung AKC, Ng C, Loo SKF.
    Recent Pat Inflamm Allergy Drug Discov; 2020 Dec; 14(2):117-132. PubMed ID: 32723274
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S, Neema S, Vashisht D, Venugopal R, Sengupta P, Radhakrishnan S.
    Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
    Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
    J Am Acad Dermatol; 2024 May; 90(5):911-926. PubMed ID: 37516356
    [Abstract] [Full Text] [Related]

  • 16. Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy.
    Nylund M, Vuorinen T, Airas L.
    Mult Scler Relat Disord; 2020 Jul; 42():102058. PubMed ID: 32208345
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B, Onamusi T, Cooley JE, McMichael AJ.
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.